Consun Pharmaceutical (01681) Announces Share Repurchases Without Changing Issued Share Capital

Bulletin Express
Oct 23

Consun Pharmaceutical Group Limited (01681) issued a Next Day Disclosure Return regarding share repurchases from 14 October 2025 to 23 October 2025. A total of 2,011,000 shares were repurchased at prices ranging from approximately HKD 14.91 to HKD 15.76 per share. Since the repurchased shares were not yet canceled as of 23 October 2025, the issued share capital remained at 847,973,407 shares.

During this period, 422,000 shares were repurchased on 23 October 2025 for an aggregate price of HKD 6,294,050. These transactions fell under a repurchase mandate granted on 22 May 2025, authorizing up to 85,126,334 shares to be bought back, equivalent to 8.4651% of the Company’s issued shares as of that date. A 30-day moratorium on new share issuances or treasury share sales is in effect until 22 November 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10